Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

George Yancopoulos President and Chief Scientific Officer at Regeneron Pharmaceuticals

Profile

George D. Yancopoulos, MD, PhD, is Regeneron’s President and Chief Scientific Officer. He has led Regeneron alongside Len Schleifer, MD, PhD, since 1989. George has been driven by science his entire life. He began his education at the Bronx High School of Science, received his MD and PhD from Columbia University and went on to become the 11th most highly cited scientist in the world in the 1990s. In 2004, he was elected to be a member of the National Academy of Sciences. Dr. Yancopoulos, together with key members of his team, is a principal inventor and developer of Regeneron's six FDA-approved drugs, as well as its foundational technologies, including the Trap technology, VelociGene® and VelocImmune®.

Agenda Sessions